Get Handpicked Stories from our editors directly to your mailbox
हिंदी में पढ़ें
Banking & Financial Services
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
Sun Pharma News
Where should you invest in June 2019? TCS to Sun Pharma - These 7 stocks are money magnets
Wed, Jun 05, 2019
Now that, PM Modi is back in office investors have entered to June 2019, where focus has shifted towards RBI monetary policy, thus one has to make most of stock markets.
Sun Pharma shares seen soaring 29%! Want to invest? CLSA and Citi shed light
Wed, May 29, 2019
Sun Pharma released its Q4FY19 performance in which the company’s net profit came in at Rs 636 crore.
Sensex closes 227 points up, Nifty at 11,318; Sun Pharma, Vedanta, Delta Corp top gainers
Tue, May 14, 2019
Sensex closes 227 points up, Nifty at 11,318; Sun Pharma, Vedanta, Delta Corp top gainers. Watch this video to know more.
Budget my pick: Top stocks before budget 2019
Tue, Jan 29, 2019
Watch this segment to know the top stocks for investment before budget 2019.
Sun Pharma stock tumbles 8.5 per cent at market closing: Should you buy? Check for Rs 420 magical figure
Fri, Jan 18, 2019
Sr. Equity Analyst, Rohit Singre, LKP Securities told Zee Business Online, ''The stock is down because of news, however technically it is weak right now. Investors are suggested to avoid until further clearance on the allegations.''
Sun Pharma tumbles on reports of fresh whistleblower complaint
Fri, Jan 18, 2019
The whistleblower alleged in a 172-page complaint that Sun Pharma`s distributor Aditya Medisales had transactions worth more than 58 billion rupees ($815 million) with Suraksha Realty, controlled by Sun`s co-promoter Sudhir Valia, a report by Moneylife magazine said.
Sun Pharma shares tumble 13% on report of fresh allegations by whistleblower
Fri, Jan 18, 2019
The whistleblower complaint alleges that an Indian pharmaceutical manufacturer Aditya Medisales Ltd had transactions with Suraksha Realty, controlled by Sun Pharma`s co-promoter, Sudhir Valia, the report stated.
Stock Market closing: Sensex finish 363 points down, Nifty below 10,800
Wed, Jan 02, 2019
The 30 share Sensex closed at Rs 35,891.72, jumping 363 points or 1 per cent down. While NSE Nifty50 fell 117 points or 1.1 per cent to close at Rs 10,792.50.
What went wrong with Sun Pharma shares? Shocks investors, plunges 11% as Dilip Shanghvi under scanner; should you invest?
Mon, Dec 03, 2018
There was massive bloodbath in the company and the shares crashed by 11.39% in an early trade today with an intraday low of Rs 441.95.
Sun Pharma, subsidiary enter settlements in Modafinil antitrust litigation
Mon, Nov 26, 2018
In a regulatory filing, Sun Pharma said "the settlements extend to all claims brought by the Direct Purchaser Plaintiffs".
Sun Pharma investors just suffered a bloodbath, but should you buy?
Wed, Nov 14, 2018
Sun Pharma saw losses in its book on the back of one-time settlement of Rs 1,214.38 crore with respect to Modafinil antitrust litigation in the US.
Stocks in Focus: State Bank of India, Infosys, Sun Pharmaceutical, Dr Reddy
Tue, Sep 25, 2018
Continuous selling pressure from the foreign institutional investors (FII), rupee depreciation, adverse macroeconomic factors, uncertainty on national and state election, and overvalued stocks and indices – all these factors together can lead to a correction in the market.
Sun Pharma gets USFDA nod for cancer treatment injection
Wed, Jul 18, 2018
This is the first US Food and Drug Administration (USFDA) approval for a product from the company's Halol facility after receipt of Establishment Inspection Report (EIR) in June 2018, Sun Pharma said in a statement.
Coffee Day, Sun Pharma among five stocks in focus today
Thu, Jul 12, 2018
Sun Pharma said its arm DUSA has filed trade secret misappropriation and tortious interference claims in an ongoing patent infringement lawsuit against Biofrontera.
As rupee takes a record plunge, these 5 stocks can earn you hefty returns
Thu, Jun 28, 2018
While rupee depreciation doesn't bode well for importers, it brings cheers for exporters who earn their revenues in rupees. We have compiled 5 stocks from export-oriented sectors such as information technology (IT) and pharma sectors for you to look at positively:
Billionaire Dilip Shanghvi gets US boost, Sun Pharma share price jumps 4%; but should you buy?
Wed, Jun 13, 2018
Sun Pharma has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the Halol facility during the period February 12-23, 2018, Sun Pharma said in a filing to BSE.
Sun Pharma, TCS among key stocks hogging limelight in Wednesday's trade
Wed, Jun 13, 2018
The Sensex and Nifty are expected to open lower tracking negative trend in Asian markets ahead of US Federal Reserve's policy outcome due later today. At 8:00 am, SGX Nifty was trading at 10,822, up 24.50 points or 0.23 per cent.
Sensex, Nifty snap two-day rally on profit-booking; Sun Pharma rallies 8% in a day
Fri, Jun 08, 2018
The Sensex ended at 35,443, down 19.41 points, while the broader Nifty50 settled at 10,767, down 0.70 points. In the broader market, the BSE Smallcap and the BSE Midcap indices gained 0.6 per cent and 0.4 per cent, respectively.
Sun Pharma top Sensex gainer; share price spikes 7% post Q4 FY18 results
Mon, May 28, 2018
Sun Pharma reported a rise of 6.96 per cent in its consolidated net profit for the quarter ended March 31, 2018 against Rs 1,223.71 crore reported for the corresponding quarter of previous fiscal year.
Sun Pharma Industries fourth-quarter profit up seven percent, beats estimates
Fri, May 25, 2018
For the year ended March 31, the drug major posted a net profit of Rs 2,161.55 crore, down 68.96per cent from Rs 6,964.37 crore in 2016-17, Sun Pharma said in a regulatory filing.